Suraj Fanse
Overview
Explore the profile of Suraj Fanse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
18
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fanse S, Bao Q, Zou Y, Wang Y, Burgess D
Int J Pharm
. 2024 Jun;
660:124343.
PMID: 38880254
The development of Levonorgestrel Intrauterine Systems (LNG-IUSs) stands as a formidable challenge due to their intricate design and reliance on specialized manufacturing methods. Pharmaceutical manufacturers face a labyrinth of process...
2.
Fanse S, Bao Q, Zou Y, Wang Y, Burgess D
J Control Release
. 2024 Apr;
370:124-139.
PMID: 38648956
The wide array of polydimethylsiloxane (PDMS) variants available on the market, coupled with the intricate combination of additives in silicone polymers, and the incomplete understanding of drug release behavior make...
3.
Kulkarni R, Fanse S, Burgess D
Expert Opin Drug Deliv
. 2023 Feb;
20(3):413-434.
PMID: 36803264
Introduction: Mucoadhesive drug delivery systems (MDDS) are specifically designed to interact and bind to the mucosal layer of the epithelium for localized, prolonged, and/or targeted drug delivery. Over the past...
4.
Kulkarni R, Fanse S, Burgess D
Expert Opin Drug Deliv
. 2023 Feb;
20(3):395-412.
PMID: 36803111
Introduction: Mucoadhesive drug delivery systems (MDDS) are specifically designed to interact and bind to the mucosal layer for localized, prolonged, and/or targeted drug delivery. Over the past 4 decades, different...
5.
Bao Q, Fanse S, Lu X, Burgess D
Int J Pharm
. 2022 Dec;
631:122532.
PMID: 36565771
Levonorgestrel intrauterine systems (LNG-IUSs) are polydimethylsiloxane (PDMS) based non-biodegradable complex drug-device combination products providing efficacy for up to several years based on the strength. A large amount of LNG (e.g.,...
6.
Fanse S, Bao Q, Burgess D
Adv Drug Deliv Rev
. 2022 Oct;
191:114581.
PMID: 36270490
Levonorgestrel intrauterine systems (LNG-IUSs) are complex drug-device combination products designed to release a hormonal contraceptive drug for up to 7 years. These drug delivery systems offers a great promise as...
7.
Fanse S, Bao Q, Zou Y, Wang Y, Burgess D
Int J Pharm
. 2021 Dec;
612:121383.
PMID: 34919997
Polydimethylsiloxane (PDMS) crosslinking density is a critical material attribute of levonorgestrel intrauterine systems (LNG-IUSs) that affects drug release and may have a significant influence on product performance and safety. Accordingly,...
8.
Fanse S, Bao Q, Zou Y, Wang Y, Burgess D
Int J Pharm
. 2021 Oct;
609:121192.
PMID: 34666142
Polydimethylsiloxane (PDMS)-based levonorgestrel intrauterine systems (LNG-IUSs) such as Mirena® are long-acting drug-device combination products designed to release LNG for contraceptive purposes up to 6 years. LNG-IUSs consist of a hollow...